skip to content
Surgeon General report on mefloquine Preview this item
ClosePreview this item
Checking...

Surgeon General report on mefloquine

Author: Canada. Department of National Defence.; Canada. Surgeon General Branch.
Publisher: [Ottawa] : [National Defence], [2017]
Edition/Format:   eBook : Document : National government publication : EnglishView all editions and formats
Summary:
"The Canadian Armed Forces (CAF) approach to malaria prevention, including use of malaria medication (called malaria chemoprophylaxis (MCP)), is consistent with the Canadian clinical practice guidelines (CPG) on malaria prevention and treatment. In most areas where the most dangerous form of malaria occurs (Plasmodium falciparum), the Canadian CPG and the CAF recommend that travelers use one of three options for  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Material Type: Document, Government publication, National government publication, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Canada. Department of National Defence.; Canada. Surgeon General Branch.
OCLC Number: 993136115
Notes: Issued also in French under title: Rapport du médecin général sur la méfloquine.
Cover title.
Description: 1 online resource (66 p.) : col. chart.
Other Titles: Surgeon General task force report on mefloquine

Abstract:

"The Canadian Armed Forces (CAF) approach to malaria prevention, including use of malaria medication (called malaria chemoprophylaxis (MCP)), is consistent with the Canadian clinical practice guidelines (CPG) on malaria prevention and treatment. In most areas where the most dangerous form of malaria occurs (Plasmodium falciparum), the Canadian CPG and the CAF recommend that travelers use one of three options for MCP: mefloquine, atovaquone-proguanil (AP) (brand name Malarone), or doxycycline. Within the CAF and with respect to these options, the current policy is that the individual member, after suitable discussion with their health care provider, can choose his/her preferred agent from among those that are deemed medically suitable. The continued use of mefloquine as a MCP option in the CAF has recently received significant scrutiny. Given the concerns that have been raised about mefloquine, the Canadian Armed Forces Chief of Defence Staff (CDS) instructed the Surgeon General (SG) to critically analyze the body of knowledge regarding mefloquine, and to undertake a review of the CAF experience with the medication. This report is the SG response to this tasking"--Introd., p. 1, 2.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/993136115> # Surgeon General report on mefloquine
    a schema:MediaObject, schema:Book, schema:CreativeWork ;
    library:oclcnum "993136115" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/onc> ;
    library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/4412103010#Place/ottawa> ; # Ottawa
    schema:about <http://experiment.worldcat.org/entity/work/data/4412103010#Topic/mefloquine_side_effects> ; # Mefloquine--Side effects
    schema:about <http://experiment.worldcat.org/entity/work/data/4412103010#Topic/malaria_prevention> ; # Malaria--Prevention
    schema:about <http://dewey.info/class/616.9/a15/> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/4412103010#Topic/paludisme_prvention> ; # Paludisme--Prv̌ention
    schema:about <http://experiment.worldcat.org/entity/work/data/4412103010#Place/canada> ; # Canada
    schema:about <http://experiment.worldcat.org/entity/work/data/4412103010#Topic/mfloquine_effets_secondaires> ; # Mf̌loquine--Effets secondaires
    schema:alternateName "Surgeon General task force report on mefloquine" ;
    schema:bookFormat schema:EBook ;
    schema:contributor <http://experiment.worldcat.org/entity/work/data/4412103010#Organization/canada_department_of_national_defence> ; # Canada. Department of National Defence.
    schema:contributor <http://experiment.worldcat.org/entity/work/data/4412103010#Organization/canada_surgeon_general_branch> ; # Canada. Surgeon General Branch.
    schema:datePublished "2017" ;
    schema:description ""The Canadian Armed Forces (CAF) approach to malaria prevention, including use of malaria medication (called malaria chemoprophylaxis (MCP)), is consistent with the Canadian clinical practice guidelines (CPG) on malaria prevention and treatment. In most areas where the most dangerous form of malaria occurs (Plasmodium falciparum), the Canadian CPG and the CAF recommend that travelers use one of three options for MCP: mefloquine, atovaquone-proguanil (AP) (brand name Malarone), or doxycycline. Within the CAF and with respect to these options, the current policy is that the individual member, after suitable discussion with their health care provider, can choose his/her preferred agent from among those that are deemed medically suitable. The continued use of mefloquine as a MCP option in the CAF has recently received significant scrutiny. Given the concerns that have been raised about mefloquine, the Canadian Armed Forces Chief of Defence Staff (CDS) instructed the Surgeon General (SG) to critically analyze the body of knowledge regarding mefloquine, and to undertake a review of the CAF experience with the medication. This report is the SG response to this tasking"--Introd., p. 1, 2."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/4412103010> ;
    schema:genre "Government publication"@en ;
    schema:genre "National government publication"@en ;
    schema:inLanguage "en" ;
    schema:name "Surgeon General report on mefloquine"@en ;
    schema:productID "993136115" ;
    schema:publication <http://www.worldcat.org/title/-/oclc/993136115#PublicationEvent/ottawa_national_defence_2017> ;
    schema:publisher <http://experiment.worldcat.org/entity/work/data/4412103010#Agent/national_defence> ; # [National Defence]
    schema:url <http://publications.gc.ca/collections/collection_2017/mdn-dnd/D2-526-2017-eng.pdf> ;
    schema:url <http://epe.lac-bac.gc.ca/100/201/301/weekly_acquisitions_list-ef/2017/17-25/publications.gc.ca/collections/collection_2017/mdn-dnd/D2-526-2017-eng.pdf> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/993136115> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/4412103010#Agent/national_defence> # [National Defence]
    a bgn:Agent ;
    schema:name "[National Defence]" ;
    .

<http://experiment.worldcat.org/entity/work/data/4412103010#Organization/canada_department_of_national_defence> # Canada. Department of National Defence.
    a schema:Organization ;
    schema:name "Canada. Department of National Defence." ;
    .

<http://experiment.worldcat.org/entity/work/data/4412103010#Organization/canada_surgeon_general_branch> # Canada. Surgeon General Branch.
    a schema:Organization ;
    schema:name "Canada. Surgeon General Branch." ;
    .

<http://experiment.worldcat.org/entity/work/data/4412103010#Topic/malaria_prevention> # Malaria--Prevention
    a schema:Intangible ;
    schema:name "Malaria--Prevention"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4412103010#Topic/mefloquine_side_effects> # Mefloquine--Side effects
    a schema:Intangible ;
    schema:name "Mefloquine--Side effects"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4412103010#Topic/mfloquine_effets_secondaires> # Mf̌loquine--Effets secondaires
    a schema:Intangible ;
    schema:name "Mf̌loquine--Effets secondaires"@fr ;
    .

<http://experiment.worldcat.org/entity/work/data/4412103010#Topic/paludisme_prvention> # Paludisme--Prv̌ention
    a schema:Intangible ;
    schema:name "Paludisme--Prv̌ention"@fr ;
    .

<http://publications.gc.ca/collections/collection_2017/mdn-dnd/D2-526-2017-eng.pdf>
    rdfs:comment "Government of Canada Publications. Freely available." ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.